Writing Interventions for Aromatase Inhibitor Medication Adherence Study

STUDY BASICS

Were you prescribed an aromatase inhibitor (AI) in the past 4 weeks, or will you be prescribed an AI in the future? You may be eligible for a research study to test whether a writing intervention improves medication adherence and reduces physical symptoms and stress. This study involves questionnaires, writing activities, and the use of an electronic pill bottle. Compensation is provided.

STUDY PURPOSE

Many women diagnosed with breast cancer take aromatase inhibitors—medicines designed to lower estrogen levels in the body and prevent certain types of breast cancers from getting the hormones they need to grow. The purpose of this research study is to find out if a writing intervention reduces physical symptoms and stress and improves medication adherence in women taking aromatase inhibitor medicines for the treatment of breast cancer.

COULD THIS STUDY BE RIGHT FOR YOU?

• Women ages 18 and up
• Diagnosed with breast cancer
• Prescribed an aromatase inhibitor as part of treatment within the past 4 weeks or anticipate being prescribed an aromatase inhibitor in the future.
• Fluent in English

WHAT PARTICIPANTS CAN EXPECT

Participation lasts about one year and involves completing questionnaires, performing  online writing activities, and using an electronic pill bottle. Participants will also be asked to have an fMRI (functional magnetic resonance imaging).